$600K from the Rett Syndrome Organization was provided prior to the IND filing, so I don't follow your logic. Also, please explain to me why Anavex's About Anavex Life Sciences Corp. section even in the most recent press releases still says the following: "The Michael J. Fox Foundation for Parkinson’s Research previously awarded Anavex a research grant to develop ANAVEX®2-73 for the treatment of Parkinson’s disease. The grant fully funded a preclinical study, which could justify moving ANAVEX®2-73 into a Parkinson’s disease clinical trial. (Bold is mine.)
Could justify moving ANAVEX®2-73 into a Parkinson's disease clinical trial? Hasn't that already been decided? Why is that language still there?
Market Data 
Markets 
AI
